Analyze Diet
Journal of veterinary pharmacology and therapeutics1981; 4(1); 43-50; doi: 10.1111/j.1365-2885.1981.tb00709.x

Cardiopulmonary effects of clenbuterol in the horse.

Abstract: Clenbuterol, a bronchospasmolytic agent (beta 2 agonist) was studied in terms of its hemodynamic and airflow response in eight, healthy horses. Four animals were instrumented to record intrapleural pressure and air flow, these were used to compute pulmonary resistance, peak flow rates, and tidal volumes. Four animals were instrumented to record pulmonary arterial pressure, carotid arterial pressure, cardiac output, and arterial gas tensions. After control values were recorded, clenbuterol (0.8 microgram/kg) was intravenously administered to each horse in each experiment group. Following clenbuterol administration, non-elastic resistance of the lung or pulmonary resistance significantly decreased, 33.6% reduction at 10 min post-clenbuterol. Pulmonary resistance remained lowered during the entire procedure and showed no tendency of returning toward control values by 3 h post-clenbuterol. Within 30 sec following clenbuterol injection carotid arterial pressure decreased (mean pressure decrease 28.2%). Accompanying the change in arterial pressure, the heart rate drastically increased, 99.0%. Both changes were transient and returned to control ranges within 2 min. Clenbuterol appears to be effective in reducing non-elastic resistance of the lung, however intravenous administration to an animal with pre-existing cardiovascular or cardiopulmonary disease should be avoided.
Publication Date: 1981-03-01 PubMed ID: 6818359DOI: 10.1111/j.1365-2885.1981.tb00709.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article explores the effects of clenbuterol, a bronchospasmolytic (lung expansion) drug, on the heart and lung function in horses. The observations indicate that the drug significantly reduces the resistance in the lungs and causes a temporary increase in heart rate and decrease in arterial pressure.

Research Methodology

  • The study involved the use of eight healthy horses. Four of these had instruments to measure intrapleural pressure and air flow for the purpose of calculating pulmonary resistance, peak flow rates, and tidal volumes. The remaining four were equipped to keep track of pulmonary arterial pressure, carotid arterial pressure, cardiac output, and arterial gas tensions.
  • Measurements were taken before and after the administration of clenbuterol to observe changes in the test subjects’ physiological responses. The dosage used for the experiment was 0.8 micrograms per kilogram of body weight for each horse, injected intravenously.

Findings and Observations

  • Clenbuterol was found to considerably reduce pulmonary resistance, with a 33.6% reduction being observed just 10 minutes after the drug’s administration. This reduced resistance level was maintained throughout the procedure, showing no sign of returning to pre-administration levels even three hours later.
  • There was a marked decrease in carotid arterial pressure, averaging at a 28.2% decrease, within 30 seconds of the clenbuterol injection. This was accompanied by an almost doubling in heart rate.
  • However, these changes were short-lived and they returned to their normal, control ranges within two minutes.

Conclusions and Recommendations

  • Clenbuterol seems to be effective in reducing the non-elastic resistance of the lung in horses. This implies potential application of such beta 2 agonists in conditions where pulmonary resistance needs to be reduced.
  • Despite the promising results, the authors caution against the intravenous administration of clenbuterol to animals with pre-existing cardiovascular or cardiopulmonary diseases, potentially due to recorded transient alterations in arterial pressure and heart rates.

Cite This Article

APA
Shapland JE, Garner HE, Hatfield DG. (1981). Cardiopulmonary effects of clenbuterol in the horse. J Vet Pharmacol Ther, 4(1), 43-50. https://doi.org/10.1111/j.1365-2885.1981.tb00709.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 4
Issue: 1
Pages: 43-50

Researcher Affiliations

Shapland, J E
    Garner, H E
      Hatfield, D G

        MeSH Terms

        • Airway Resistance / drug effects
        • Animals
        • Blood Pressure / drug effects
        • Carbon Dioxide / blood
        • Cardiac Output / drug effects
        • Clenbuterol / pharmacology
        • Ethanolamines / pharmacology
        • Hemodynamics / drug effects
        • Horses / physiology
        • Hydrogen-Ion Concentration
        • Lung / drug effects
        • Oxygen / blood
        • Time Factors

        Citations

        This article has been cited 2 times.
        1. Donaldson LL. A review of the pathophysiology of exercise-induced pulmonary haemorrhage in the equine athlete. Vet Res Commun 1991;15(3):211-26.
          doi: 10.1007/BF00343226pubmed: 1882515google scholar: lookup
        2. Kataveni S, Gourishetty RP, Mundada SM, Avvaru MP, Kollipara VS, Gottimukkala SP. Clenbuterol Abuse in Bodybuilding and Athletics: Unsupervised Use, Psychological Motivations, and Health Consequences. Cureus 2025 May;17(5):e84904.
          doi: 10.7759/cureus.84904pubmed: 40575216google scholar: lookup